Qianjiang Yongan Pharmaceutical Co Ltd (002365) — Free Cash Flow Generation Index
Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Free Cash Flow Generation Index of 0.80x as of September 2025. Free cash flow of CN¥46.33 Million represents 1% of operating cash flow (CN¥58.18 Million). Explore 002365 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Qianjiang Yongan Pharmaceutical Co Ltd Free Cash Flow Generation Index (2006–2024)
Historical FCF Generation Index trend for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. For the full cash flow conversion analysis, see Qianjiang Yongan Pharmaceutical Co Ltd cash conversion from operations.
Annual Free Cash Flow Generation for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Year-by-year Free Cash Flow Generation Index for Qianjiang Yongan Pharmaceutical Co Ltd. Check how aggressively does Qianjiang Yongan Pharmaceutical Co Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.12x | CN¥-12.33 Million | CN¥105.71 Million | CN¥118.04 Million | ▼ -128.4% |
| 2023 | 0.41x | CN¥100.46 Million | CN¥244.26 Million | CN¥120.74 Million | ▼ -33.1% |
| 2022 | 0.62x | CN¥238.21 Million | CN¥387.28 Million | CN¥149.07 Million | ▲ +61.6% |
| 2021 | 0.38x | CN¥38.76 Million | CN¥101.81 Million | CN¥63.05 Million | ▼ -23.1% |
| 2020 | 0.49x | CN¥102.25 Million | CN¥206.66 Million | CN¥104.41 Million | ▲ +12.7% |
| 2019 | 0.44x | CN¥105.15 Million | CN¥239.55 Million | CN¥134.39 Million | ▲ +209.6% |
| 2018 | 0.14x | CN¥44.53 Million | CN¥314.02 Million | CN¥269.50 Million | ▲ +130.4% |
| 2017 | -0.47x | CN¥-92.15 Million | CN¥197.32 Million | CN¥289.47 Million | ▼ -188.9% |
| 2016 | 0.53x | CN¥44.40 Million | CN¥84.53 Million | CN¥40.13 Million | ▲ +1.6% |
| 2015 | 0.52x | CN¥36.49 Million | CN¥70.61 Million | CN¥34.12 Million | ▲ +131.7% |
| 2014 | -1.63x | CN¥-31.42 Million | CN¥19.26 Million | CN¥50.69 Million | ▼ -186.2% |
| 2013 | -0.57x | CN¥-36.28 Million | CN¥63.65 Million | CN¥99.93 Million | ▲ +18.4% |
| 2012 | -0.70x | CN¥-49.43 Million | CN¥70.75 Million | CN¥120.18 Million | ▲ +59.3% |
| 2011 | -1.72x | CN¥-156.80 Million | CN¥91.23 Million | CN¥248.03 Million | ▼ -25.3% |
| 2010 | -1.37x | CN¥-60.45 Million | CN¥44.06 Million | CN¥104.52 Million | ▼ -423.5% |
| 2009 | -0.26x | CN¥-9.55 Million | CN¥36.43 Million | CN¥45.98 Million | ▼ -148.1% |
| 2008 | 0.54x | CN¥86.28 Million | CN¥158.47 Million | CN¥72.19 Million | ▲ +10707.9% |
| 2007 | 0.01x | CN¥307.69K | CN¥61.08 Million | CN¥60.77 Million | ▼ -98.8% |
| 2006 | 0.43x | CN¥13.44 Million | CN¥31.11 Million | CN¥17.68 Million | — |